Source: International Congress 2019 – Airway regenerative medicine: from bench to bedside
Disease area: -



Rating:

Share or cite this content

Citations should be made in the following way:
C. Happle (Hannover, Germany). Pulmonary transplantation of human induced pluripotent stem cell-derived macrophages. International Congress 2019 – Airway regenerative medicine: from bench to bedside

Member's Comments

No comment yet.

Related content which might interest you: Induced pluripotent stem cell-derived alveolar epithelial cells: applications with lung-on-a-chip Source: International Congress 2019 – Airway regenerative medicine: from bench to bedside Year: 2019 PP206 – Modeling idiopathic pulmonary fibrosis using induced pluripotent stem cell-derived alveolar epithelial organoids Source: ERS Lung Science Conference 2021 Year: 2021 LSC - 2021 - Modeling idiopathic pulmonary fibrosis using induced pluripotent stem cell-derived alveolar epithelial organoids Source: Virtual Congress 2021 – In vitro modelling of lung disease: reach out to the next dimension Year: 2021 Induced pluripotent stem cells for generating lung airway stem cells and modelling respiratory disease Source: Eur Respir Monogr 2021; 91: 190-204 Year: 2021 Modelling human lung development and disease using pluripotent stem cells Source: International Congress 2015 – Regenerative medicine of the lung: opportunities and threats Year: 2015 Induced pluripotent stem cell derived macrophages differentiate into AM like cells in the lungs of humanized PAP mice Source: International Congress 2017 – Paediatric bronchology in clinical practice Year: 2017 Using induced pluripotent stem cells to model the human lung alveolar epithelium Source: International Congress 2018 – Pathophysiology of the human lung alveolus Year: 2018 Induced pluripotent stem cells for generating lung alveolar epithelial cells and modelling respiratory disease Source: Eur Respir Monogr 2021; 91: 205-221 Year: 2021 Oral presentation: Mesenchymal induction of lung endoderm progenitor cells from embryonic stem cells Source: Lung Science Conference 2009 - Cell proliferation, Differentiation and Carcinogenesis Year: 2009 Mesenchymal stem cells in aging and IPF Source: ERS Research Seminar 2017 – Integrating systems biology approach in idiopathic pulmonary fibrosis research Year: 2016 Secreted mediators from induced pluripotent stem cells (iPSc) attenuate fibrosis in bleomycin injured rat lung Source: Annual Congress 2012 - Stem cells and progenitors in injury and repair Year: 2012 Evaluation of cadmium cytotoxicity using alveolar epithelial cells derived from human induced pluripotent stem cells Source: International Congress 2017 – Translational studies of lung disease Year: 2017 Generation and Immunogenicity of induced pluripotent stem cells Source: Research Seminar 2014 - The many faces of stem cells in respiratory diseases Year: 2014 Sarcoidosis in donor-derived tissues after haematopoietic stem cell transplantation Source: Eur Respir J 2013; 41: 1452-1453 Year: 2013 Engineering distal pulmonary epithelium from induced pluripotent stem cell (iPSC)-derived alveolar cells Source: International Congress 2019 – Extracellular matrix formation and remodelling in physiology and disease Year: 2019 Early lung function alterations after allogeneic hematopoietic stem cell transplantation Source: Annual Congress 2010 - Mechanisms and modulation of allergic inflammation in the lung Year: 2010